Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RILUZOLE vs RIPRETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RILUZOLE vs RIPRETINIB: Safety Overview

Metric RILUZOLE RIPRETINIB
Total FAERS Reports 1,437 4,432
Deaths Reported 342 465
Death Rate 23.8% 10.5%
Hospitalizations 264 948
Average Patient Age 63.5 yrs 66.8 yrs
% Female Patients 47.5% 45.3%
FDA Approval Date Aug 22, 2024 May 15, 2020
Manufacturer EDW PHARMA Deciphera Pharmaceuticals, LLC
Route ORAL ORAL
Marketing Status Discontinued Prescription